Bicara Therapeutics Inc. Common Stock

BCAX

BCAXBicara Therapeutics Inc. Common Stock US flag

NASDAQ Global Market

28.15

USD

+1.00

- -

1.54BMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	38	40	82	156
+ Selling, General & Admin	6	9	19	31
+ Research & Development	31	31	64	125
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-38	-40	-82	-156
- Non-Operating (Income) Loss	- -	12	-15	-18
+ Interest Expense, Net	- -	-1	-15	-18
+ Interest Expense	- -	- -	- -	- -
- Interest Income	- -	1	15	18
+ Other Non-Op (Income) Loss	- -	13	- -	- -
Pretax Income	-38	-52	-68	-138
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-38	-52	-68	-138
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-38	-52	-68	-138
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-38	-52	-68	-138
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-38	-52	-68	-138
EBIT	-38	-40	-82	-156
EBITDA	-38	-40	-82	-155
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-38	-40	-82	-156
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	15	34	17	55
Basic EPS, GAAP	-2.45	-1.53	-4.05	-2.52
Basic EPS from Cont Ops	-2.45	-1.53	-4.05	-2.52
Diluted Weighted Avg Shares	15	34	17	55
Diluted EPS, GAAP	-2.45	-1.53	-4.05	-2.52
Diluted EPS from Cont Ops	-2.45	-1.53	-4.05	-2.52

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	5	231	503	422
+ Cash, Cash Equivalents & STI	4	230	490	415
+ Cash & Cash Equivalents	4	230	490	97
+ ST Investments	- -	- -	- -	318
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	1	13	7
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	2	3	7	9
+ Property, Plant & Equip, Net	1	1	1	2
+ Property, Plant & Equip	1	1	1	2
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	1	2	7	7
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	1	2	7	7
Total Assets	7	234	510	431
+ Payables & Accruals	23	13	14	23
+ Accounts Payable	5	3	5	8
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	18	10	10	15
+ ST Debt	- -	- -	1	1
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	1	1
+ Other ST Liabilities	1	2	3	5
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	1	2	3	5
Total Current Liabilities	24	15	18	29
+ LT Debt	- -	- -	- -	1
+ LT Borrowings	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	1
+ Other LT Liabilities	82	367	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	82	367	- -	- -
Total Noncurrent Liabilities	82	368	- -	1
Total Liabilities	106	383	18	30
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	2	4	713	760
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	2	4	713	760
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-101	-153	-221	-359
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-99	-149	492	401
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-99	-149	492	401
Total Liabilities & Equity	7	234	510	431
Shares Outstanding	52	52	54	57
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	1	1	2
Net Debt	-4	-230	-490	-97
Net Debt to Equity	4.21	154.9	-99.56	-24.08
Tangible Common Equity Ratio	-1,474.01	-63.58	96.45	93.15
Current Ratio	0.21	15.32	27.93	14.58
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-38	-52	-68	-138
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	1	16	7	16
+ Stock-Based Compensation	1	2	7	15
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	1	- -	- -
+ Other Non-Cash Adj	- -	13	- -	1
+ Chg in Non-Cash Work Cap	5	-10	-14	15
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	-1	-17	5
+ Inc (Dec) in Accts Payable	6	-9	3	10
+ Inc (Dec) in Other	- -	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-32	-46	-75	-107
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	-1	- -	- -
+ Acq of Fixed Prod Assets	- -	-1	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	332	29
+ Increase in Capital Stock	- -	- -	332	29
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	-318
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	-318
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	-1	- -	-318
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	32	272	2	3
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	32	272	334	32
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	-1	226	259	-393
EBITDA	-38	-40	-82	-155
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-32	-46	-75	-107
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-46	-75	-107
Free Cash Flow per Basic Share	-2.09	-1.36	-4.45	-1.96
Price/Free Cash Flow	- -	- -	-3.92	-8.64
Cash Flow to Net Income	0.85	0.88	1.1	0.77
Capital Expenditures	- -	-1	- -	- -